Adaptive Hypofractionated Radiotherapy for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Apr 2026: Trial registered, NCT07516210

The trials

NCT07516210: Adaptive Radiotherapy for Safe Hypofractionation

State
Not started
Phase
Phase 2
People
264 planned
Started
Nov 2026
Primary completion
May 2030
Arms
Adaptive Hypofractionated Radiotherapy (ART-Hypo)
Results
None posted
  1. 7 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.